Synthesis and characterization of selenotrisulfide-derivatives of lipoic acid and lipoamide.
Thiol-containing compounds, such as glutathione and cysteine, react with selenite under specific conditions to form selenotrisulfides. Previous studies have focused on isolation and characterization of intermolecular selenotrisulfides. This study describes the preparation and characterization of intramolecular selenotrisulfide derivatives of lipoic acid and lipoamide. These derivatives, after separation from other reaction products by reverse-phase HPLC, exhibit an absorbance maximum at 288 nm with an extinction coefficient of 1,500 M(-1) small middle dotcm(-1). The selenotrisulfide derivative of lipoic acid was significantly stable at or below pH 8.0 in contrast to several other previously studied selenotrisulfides. Mass spectral analysis of the lipoic acid and lipoamide derivatives confirmed both the expected molecular weights and also the presence of a single atom of selenium as revealed by its isotopic distribution. The selenotrisulfide derivative of lipoic acid was found to serve as an effective substrate for recombinant human thioredoxin reductase as well as native rat thioredoxin reductase in the presence of NADPH. Likewise, the lipoamide derivative was efficiently reduced by NADH-dependent bovine lipoamide dehydrogenase. The significant in vitro stability of these intramolecular selenotrisulfide derivatives of lipoic acid can serve as an important asset in the study of such selenium adducts as model selenium donor compounds for selenophosphate biosynthesis and as rate enhancement effectors in various redox reactions.
Self
W T
WT
Laboratory of Biochemistry, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892, USA. selfw@nhlbi.nih.gov
Tsai
L
L
Stadtman
T C
TC
D000818:Animals; D002417:Cattle; D002851:Chromatography, High Pressure Liquid / Q000379:methods; D008058:Dihydrolipoamide Dehydrogenase / Q000378:metabolism; D006801:Humans; D006863:Hydrogen-Ion Concentration; D015394:Molecular Structure; D010084:Oxidation-Reduction; D051381:Rats; D011994:Recombinant Proteins / Q000378:metabolism; D018036:Selenium Compounds / Q000737:chemistry* / Q000302:isolation & purification / Q000378:metabolism; D018038:Sodium Selenite / Q000737:chemistry; D013440:Sulfides / Q000737:chemistry* / Q000302:isolation & purification / Q000378:metabolism; D008063:Thioctic Acid / Q000031:analogs & derivatives* / Q000737:chemistry* / Q000302:isolation & purification / Q000378:metabolism; D013880:Thioredoxin-Disulfide Reductase / Q000378:metabolism
D011994:Recombinant Proteins; D018036:Selenium Compounds; D013440:Sulfides; C059755:selenotrisulfide; C007409:dihydrolipoamide; D008063:Thioctic Acid; C015144:dihydrolipoic acid; C013091:lipoamide; D008058:Dihydrolipoamide Dehydrogenase; D013880:Thioredoxin-Disulfide Reductase; D018038:Sodium Selenite